7Hunt SA,Baker DW,Chin MH,et al.ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).J Am Coll Cardiol,2001,38:2101-2113.
8Hunt SA,Baker DW,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).J Am Coll Cardiol,2005,46:1-82.
9Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
10Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
7Gislason GH,Rasmussen JN,Abildstrom SZ,et al.Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes[J].Circulation,2007,116:737-744.
8Komajda M,Lapuerta P,Hermans N,et al.Adherence to guidelines is a predictor of outcome in chronic heart failure:the MAHLER survey[J].Eur Heart J,2005,26:1653-1659.
